Atlas Trials

Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers

Clinical trial NCT04404595 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04404595
Sponsor
CARsgen Therapeutics Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Gastric CancerPancreatic Cancer
Start date
2020-10-23
Primary completion
2025-06-01
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.